Angelo Pozo-Gamez
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: February 02, 2026
NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.
Journal: International journal of molecular sciences
Published: January 26, 2026
Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer in vivo model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 16, 2025
Identification of a Muscle-Invasive Bladder Carcinoma Molecular Subtype of Poor Responders to Neoadjuvant Chemotherapy and High Expression of Targetable Biomarkers.
Journal: International journal of molecular sciences
Published: November 18, 2025
Protein content of extracellular vesicles from patients with advanced melanoma changes upon progression to anti-PD1 therapy.
Journal: Scientific reports
Published: October 09, 2025
Monitoring of low-risk pancreatic cystic lesions with targeted abdominal ultrasound: diagnostic yield, clinical utility, and acceptance.
Journal: Ultrasonography (Seoul, Korea)
Published: September 16, 2025
Monitoring of low-risk pancreatic cystic lesions with targeted abdominal ultrasound: diagnostic yield, clinical utility, and acceptance.
Journal: Ultrasonography (Seoul, Korea)
Published: September 16, 2025
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.
Journal: British journal of cancer
Published: November 04, 2024
Layer Analysis Based on RNA-Seq Reveals Molecular Complexity of Gastric Cancer.
Journal: International journal of molecular sciences
Published: September 11, 2024
Functional proteomics of colon cancer Consensus Molecular Subtypes.
Journal: British journal of cancer
Published: October 27, 2023
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 15, 2023
Last Updated: 09/26/2026